Reimportation of Pharmaceuticals: Economic and Policy Implications
This supplement explores the reasons for international price differences in drugs and examines the economic and quality ramifications of increased use of reimported pharmaceuticals. In addition, a panel of experts considers the characteristics of pharmaceuticals procured through nontraditional distribution channels. The perspectives of various stakeholder groups are presented. Based on a conference hosted by the University of Michigan Center for Medication Use, Policy, and Economics.
- Differentials in International Pharmaceutical Expenditure
- Overview From the National Association of Boards of Pharmacy
- Economics and Risk of Reimported Pharmaceuticals
- Vulnerable Points in the U.S. Drug-Distribution System
- Reimportation and the Consumer
- FDA Quality Assurance and Reimportation